Updated from 4:35 a.m. EDT

Novartis ( NVS) said third-quarter earnings from continuing operations rose 32% to $2.1 billion and sales rose 12% to $10.7 billion as pharmaceuticals sales rose ahead of expectations and its U.S. business returned to growth.

The Swiss drug maker also said Monday it plans to cut about 550 full-time positions in its U.S. sales force. The company will record a fourth-quarter charge of about $20 million.

Novartis also reaffirmed expectations for a year of record net sales and earnings in 2008.

Novartis also appointed Joerg Reinhardt as chief operating officer. He formerly served as head of vaccines and diagnostics.

More from Stocks

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Flashback Friday: Amazon, Chip Stocks, Memorial Day

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain